U.S. markets open in 6 hours 28 minutes

Akero Therapeutics, Inc. (AKRO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
23.60+0.36 (+1.55%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
Total Revenue
0
0
0
0
Operating Expense
95,415
80,154
45,651
13,778
Operating Income
-95,415
-80,154
-45,651
-13,778
Other Income Expense
278
947
1,896
-67,936
Pretax Income
-95,137
-79,207
-43,755
-81,714
Net Income Common Stockholders
-95,137
-79,207
-43,755
-19,564
Diluted NI Available to Com Stockholders
-95,137
-79,207
-43,755
-19,564
Basic EPS
-
-2.52
-2.90
-3.12
Diluted EPS
-
-2.52
-2.90
-3.12
Basic Average Shares
-
31,463
15,071
6,277
Diluted Average Shares
-
31,463
15,071
6,277
Total Operating Income as Reported
-95,415
-80,154
-45,651
-13,778
Total Expenses
95,415
80,154
45,651
13,778
Net Income from Continuing & Discontinued Operation
-95,137
-79,207
-43,755
-81,714
Normalized Income
-95,137
-79,207
-43,755
-81,714
EBIT
-95,415
-80,154
-45,651
-13,778
EBITDA
-95,377
-
-
-
Reconciled Depreciation
38
17
-
-
Net Income from Continuing Operation Net Minority Interest
-95,137
-79,207
-43,755
-81,714
Normalized EBITDA
-95,377
-80,137
-45,651
-13,778
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0